HELIX BIOPHARMA CORP (HBP.CA) Stock Overview
Canada - TSX:HBP - CA4229102088 - Common Stock
HBP.CA Key Statistics, Chart & Performance
The current stock price of HBP.CA is 2.48 CAD. In the past month the price increased by 65.33%. In the past year, price increased by 106.67%.
HBP.CA Latest News, Press Relases and Analysis
HBP.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 457.82M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 412.90M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 340.64M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 135.67M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 82.28M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 74.23M | ||
| NRX.CA | NUREXONE BIOLOGIC INC | N/A | 72.56M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 26 | 57.03M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 44.58M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 35.64M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 32.32M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 31.54M |
Related stock screener links
About HBP.CA
Company Profile
Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. The company is headquartered in Toronto, Ontario and currently employs 7 full-time employees. The Company’s pipeline is led by Tumor Defense Breaker L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with the Company's next-generation bi-specific antibody-drug conjugates (ADCs), in discovery. The firm is also advancing two pre-IND candidates: LEUMUNA, an oral immune checkpoint modulator aimed at achieving durable remission in post-transplant leukemia relapse, and GEMCEDA, an oral gemcitabine prodrug with bioavailability on a par with IV, designed to expand treatment options for advanced cancers.
Company Info
HELIX BIOPHARMA CORP
Bay Adelaide Centre - North Tower 40, Temperance Street, Suite 2700 Toronto
TORONTO ONTARIO L4B 3J9 CA
CEO: Heman Chao
Employees: 7
Phone: 16046842181
HELIX BIOPHARMA CORP / HBP.CA FAQ
What is the stock price of HELIX BIOPHARMA CORP today?
The current stock price of HBP.CA is 2.48 CAD. The price decreased by -0.8% in the last trading session.
What is the ticker symbol for HELIX BIOPHARMA CORP stock?
The exchange symbol of HELIX BIOPHARMA CORP is HBP and it is listed on the Toronto Stock Exchange exchange.
On which exchange is HBP.CA stock listed?
HBP.CA stock is listed on the Toronto Stock Exchange exchange.
What is HELIX BIOPHARMA CORP worth?
HELIX BIOPHARMA CORP (HBP.CA) has a market capitalization of 189.42M CAD. This makes HBP.CA a Micro Cap stock.
How many employees does HELIX BIOPHARMA CORP have?
HELIX BIOPHARMA CORP (HBP.CA) currently has 7 employees.
What are the support and resistance levels for HELIX BIOPHARMA CORP (HBP.CA) stock?
HELIX BIOPHARMA CORP (HBP.CA) has a support level at 2.39. Check the full technical report for a detailed analysis of HBP.CA support and resistance levels.
Should I buy HELIX BIOPHARMA CORP (HBP.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HBP.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HBP.CA, evaluating the profitability, health, valuation and growth aspects
- HELIX BIOPHARMA CORP (HBP.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HELIX BIOPHARMA CORP (HBP.CA) Sales and EPS estimates to see what analysts future expectations are.
- HELIX BIOPHARMA CORP (HBP.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HELIX BIOPHARMA CORP (HBP.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- HELIX BIOPHARMA CORP (HBP.CA) Stock Chart to make your own analysis
- HELIX BIOPHARMA CORP (HBP.CA) Latest news and press-releases to stay up to date.
Does HELIX BIOPHARMA CORP (HBP.CA) stock pay dividends?
HBP.CA does not pay a dividend.
When does HELIX BIOPHARMA CORP (HBP.CA) report earnings?
HELIX BIOPHARMA CORP (HBP.CA) will report earnings on 2025-10-22.
What is the Price/Earnings (PE) ratio of HELIX BIOPHARMA CORP (HBP.CA)?
HELIX BIOPHARMA CORP (HBP.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).
HBP.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to HBP.CA. When comparing the yearly performance of all stocks, HBP.CA is one of the better performing stocks in the market, outperforming 92.7% of all stocks.
HBP.CA Financial Highlights
Over the last trailing twelve months HBP.CA reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -76.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -944.8% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |